Adipose tissue 11HSD1 gene expression, cell function and ectopic fat in obese African Americans versus Hispanics

被引:5
作者
Gyllenhammer, Lauren E. [1 ]
Alderete, Tanya L. [1 ]
Mahurka, Swapna [1 ]
Allayee, Hooman [1 ]
Goran, Michael I. [1 ]
机构
[1] Univ So Calif, Dept Prevent Med, Diabet & Obes Res Inst, Los Angeles, CA 90089 USA
关键词
11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; INSULIN-RESISTANCE; LIVER-DISEASE; HYPERINSULINEMIA; STIMULATION; LIPOLYSIS; STRESS; ACIDS; MICE;
D O I
10.1002/oby.20571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study examined the contribution of subcutaneous adipose tissue (SAT) 11HSD1 to obese African Americans' (AA) elevated metabolic risk, despite a protective obesity phenotype of reduced visceral adipose tissue (VAT) and hepatic fat fraction (HFF) relative to obese Hispanics with similar metabolic risk. Design and Methods Obese AA and Hispanic adults (N = 36(16AA); BMI 35.2 +/- 0.6 kg/m2, 18-25y) participated, with VAT, SAT, and HFF measured by MRI, SAT gene expression measured by HT-12 microarray and insulin sensitivity (SI), disposition index (DI) by IVGTT. Multiple linear regression examined relationships/interactions of ethnicity and 11HSD1 expression on outcomes (covariates: age, sex, total fat mass), with standardized (st) reported. Results SAT 11HSD1 expression significantly associated with insulin parameters and this varied by ethnicity (Pinteraction<0.1). In AA, 11HSD1 negatively associated with SI (st = -0.58, P = 0.03), DI (st = -0.62, P = 0.03) and positively associated with fasting insulin (st = 0.54, P = 0.04), with no significant relationship in Hispanics. SAT 11HSD1 associated with HFF in the combined sample (st = 0.42, P = 0.008), with no difference between ethnicites (Pinteraction>0.1). After controlling for HFF, 11HSD1 associations with metabolic risk in AA became nonsignificant. Conclusions These results suggested that in AA and not Hispanics, SAT 11HSD1 is associated with SI and DI, and may be mediated by HFF.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 20 条
[1]  
ALDERETE TL, JCEM IN PRESS
[2]   THE MODERATOR MEDIATOR VARIABLE DISTINCTION IN SOCIAL PSYCHOLOGICAL-RESEARCH - CONCEPTUAL, STRATEGIC, AND STATISTICAL CONSIDERATIONS [J].
BARON, RM ;
KENNY, DA .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1986, 51 (06) :1173-1182
[3]   Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis [J].
Biddinger, Sudha B. ;
Hernandez-Ono, Antonio ;
Rask-Madsen, Christian ;
Haas, Joel T. ;
Aleman, Jose O. ;
Suzuki, Ryo ;
Scapa, Erez F. ;
Agarwal, Chhavi ;
Carey, Martin C. ;
Stephanopoulos, Gregory ;
Cohen, David E. ;
King, George L. ;
Ginsberg, Henry N. ;
Kahn, C. Ronald .
CELL METABOLISM, 2008, 7 (02) :125-134
[4]   Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease [J].
Candia, Roberto ;
Riquelme, Arnoldo ;
Baudrand, Rene ;
Carvajal, Cristian A. ;
Morales, Mauricio ;
Solis, Nancy ;
Pizarro, Margarita ;
Escalona, Alex ;
Carrasco, Gonzalo ;
Boza, Camilo ;
Perez, Gustavo ;
Padilla, Oslando ;
Cerda, Jaime ;
Fardella, Carlos E. ;
Arrese, Marco .
LIVER INTERNATIONAL, 2012, 32 (03) :392-399
[5]   THE MODIFIED MINIMAL MODEL - APPLICATION TO MEASUREMENT OF INSULIN SENSITIVITY IN CHILDREN [J].
CUTFIELD, WS ;
BERGMAN, RN ;
MENON, RK ;
SPERLING, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (06) :1644-1650
[6]   STIMULATION OF LIPOLYSIS IN HUMANS BY PHYSIOLOGICAL HYPERCORTISOLEMIA [J].
DIVERTIE, GD ;
JENSEN, MD ;
MILES, JM .
DIABETES, 1991, 40 (10) :1228-1232
[7]  
Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI200523621, 10.1172/JCI23621]
[8]   Short- and long-term glucocorticoid treatment enhances insulin signalling in human subcutaneous adipose tissue [J].
Gathercole, L. L. ;
Morgan, S. A. ;
Bujalska, I. J. ;
Stewart, P. M. ;
Tomlinson, J. W. .
NUTRITION & DIABETES, 2011, 1 :e3-e3
[9]   Ethnic Differences in Hepatic Steatosis: An Insulin Resistance Paradox? [J].
Guerrero, Richard ;
Vega, Gloria L. ;
Grundy, Scott M. ;
Browning, Jeffrey D. .
HEPATOLOGY, 2009, 49 (03) :791-801
[10]  
HAZLEHURST JM, 2013, J CLIN ENDOCRINOL ME